Literature DB >> 1446228

Post-ischemic administration of bifemelane hydrochloride prohibits ischemia-induced depletion of the muscarinic M1-receptor and its mRNA in the gerbil hippocampus.

N Ogawa1, M Asanuma, K Mizukawa, H Hirata, H Chou, A Mori.   

Abstract

Parallel determinations of muscarinic cholinergic M1 receptor (M1-R) binding and of M1-R mRNA levels were carried out in the gerbil hippocampus 14 days after 5 min of transient ischemia. Both were reduced in the ischemic tissue to about 50% of the levels found in sham-operated controls, indicating that the late loss of M1-R is probably dependent on decreased synthesis. Three administrations of bifemelane hydrochloride (15 mg/kg, i.p., just after ischemia and 6 and 12 h later) completely prevented neuronal death in the hippocampus and ischemia-induced losses of hippocampal M1-R and its mRNA. Since vascular dementia may depend upon the ischemia-induced losses in cholinergic communication in the hippocampus, these findings suggest that it may be possible to prevent its occurrence by post-ischemic treatment with bifemelane hydrochloride.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446228     DOI: 10.1016/0006-8993(92)90993-j

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Chronic administration of Oren-gedoku-to (TJ15) inhibits ischemia-induced changes in brain indoleamine metabolism and muscarinic receptor binding in the Mongolian gerbil.

Authors:  H Kabuto; M Asanuma; S Nishibayashi; M Iida; N Ogawa
Journal:  Neurochem Res       Date:  1997-01       Impact factor: 3.996

2.  Bifemelane hydrochloride protects against cytotoxicity of hydrogen peroxide on cultured rat neuroblastoma cell line.

Authors:  I Miyazaki; E Iwata-Ichikawa; M Asanuma; M Iida; N Ogawa
Journal:  Neurochem Res       Date:  1999-07       Impact factor: 3.996

3.  Post-ischemic administration of the acetylcholinesterase inhibitor ENA-713 prevents delayed neuronal death in the gerbil hippocampus.

Authors:  K Tanaka; K Mizukawa; N Ogawa; A Mori
Journal:  Neurochem Res       Date:  1995-06       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.